This trial aims to develop evidence based curative treatment with optimal net benefit for patients with Brugada syndrome.
Who can participate
Age range18 Years – 80 Years
SexALL
See this in plain English?
AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.
Inclusion Criteria:
* The diagnosis of Brugada syndrome is based on 2013 HRS/EHRA/APHRS Consensus document criteria
* Diagnosed symptomatic BrS with an implanted ICD within the last 5 years
* Diagnosed symptomatic BrS with an implanted ICD longer than 5 years but has at least 1 appropriate shock within the last 5 years
* The patient is legally competent, willing and able to undergo the study and signed the informed consent
* The patient is willing and able to adhere to the follow-up visit protocol
Exclusion Criteria:
* A patient who does not meet inclusion criteria
* A patient who has had a previous epicardial ablation
* A patient who is pregnant (which would exclude an ablation procedure)
* A patient with a co-morbid condition that possesses undue risk of general anesthesia or epicardial ablation
* A patient who has a history of radiation therapy on the thorax
What they're measuring
1
Freedom of Ventricular Fibrillation/Tachycardia Recurrences
Timeframe: 3 year followup
Trial details
NCT IDNCT02704416
SponsorPacific Rim Electrophysiology Research Institute